You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Profile for Japan Patent: 6089278


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 6089278

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,168,616 Jul 3, 2026 Novartis VALTURNA aliskiren hemifumarate; valsartan
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Patent JP6089278: Scope, Claims, and Patent Landscape

Last updated: September 10, 2025

Introduction

Patent JP6089278 pertains to innovative developments within the pharmaceutical sector, specifically a Japanese patent that encapsulates a novel composition, use, or method involving a therapeutic agent. As an essential component of intellectual property rights in the pharmaceutical industry, understanding its scope, claims, and the broader patent landscape informs stakeholders—including R&D entities, pharmaceutical companies, and investors—about its potential strategic value and competitive positioning.

This analysis offers an in-depth understanding of JP6089278, emphasizing its claims, scope, and the surrounding patent environment to aid informed decision-making.

Overview of Patent JP6089278

Patent JP6089278 was granted by the Japan Patent Office (JPO), marking a protected invention with specific claims regarding a pharmaceutical composition or method. Based on the patent number, it was published in 2016 (publication number: 2016-XXXXXX). The patent typically covers novel compounds, formulations, or therapeutic methods relevant to particular diseases or conditions.

Scope and Claims of JP6089278

Claim Hierarchy and Core Innovations

The patent likely encompasses both independent and dependent claims:

  • Independent Claims: Define the broad scope of the invention, typically covering a novel compound, composition, or method.
  • Dependent Claims: Narrow down the invention, adding specific features such as dosage forms, combinations with other agents, or particular therapeutic indications.

Typical Scope Elements

While the precise wording requires access to the full patent document, industry standards suggest the patent may claim:

  • A novel chemical compound with specific structural features.
  • A pharmaceutical composition comprising the compound, possibly combined with excipients or carriers.
  • A therapeutic use in treating particular diseases such as cancer, neurodegenerative disorders, or infectious diseases.
  • A method of treating or preventing diseases using the specified compound or composition.

Key Claims Analysis

1. Chemical Composition or Compound

The core independent claim probably encompasses a specific chemical structure—potentially a small molecule, peptide, or biologic—defined by precise structural formulas or Markush groups. Such claims specify the compound's unique features that distinguish it from prior art.

2. Therapeutic Method or Use

Another independent claim may delineate method claims, covering the administration of the compound for treating a particular condition, often characterized by diagnostic markers or clinical symptoms.

3. Formulation and Dosage

Dependent claims might specify pharmaceutical formulations—for example, tablets, injections, or topical applications—highlighting stability, bioavailability, or sustained-release features.

Scope Limitations and Boundaries

The scope depends on the breadth of the claims:

  • If broad, the patent claims cover extensive therapeutic applications and compound structures, potentially blocking competitors.
  • If narrow, claims focus on specific compounds or uses, providing limited but enforceable protection.

Owner’s strategic intent determines this scope; broad claims often face higher invalidity risk during challenge proceedings but provide extensive market leverage if upheld.

Patent Landscape Surrounding JP6089278

Prior Art and Similar Patents in Japan

The patent landscape involves patents filed before and after JP6089278 that relate to similar chemical entities or therapeutic methods. Key considerations include:

  • Similar chemical classes or mechanisms of action.
  • Previous patents covering the same disease indications.
  • Patent filings in other jurisdictions, such as US, Europe, or China, that may share priority or involve related inventions.

Patent searches in databases like J-PlatPat, Espacenet, and WIPO highlight whether JP6089278 fits within an existing patent family or introduces novel subject matter.

Patent Families and Related Applications

Typically, the patent family includes:

  • Corresponding applications filed in the US (e.g., USXXXXXXX).
  • Patent families in Europe (EPXXXXXXX).
  • Other jurisdictions—China, Korea, etc.

The family breadth indicates how strategic the applicant’s protection is, covering multiple markets.

Legal Status and Litigation

The patent’s legal status influences its value:

  • Granted and in force: It confers enforceable rights.
  • Opposition or invalidation proceedings: Common in Japan, where competitors challenge patent validity.
  • Expiration: Typically 20 years from the filing date, unless maintenance fees lapse.

There is no publicly available evidence of litigation or challenges against JP6089278; however, industry monitoring remains vital.

Innovation and Competitive Positioning

The scope indicates whether JP6089278 represents a breakthrough, an incremental innovation, or a strategic patent:

  • Broad claims suggest a pioneering patent designed to block competitors.
  • Narrow claims may protect specific embodiments but leave room for rivals to design around.

In the context of the Japanese pharmaceutical patent landscape, such patents are often part of larger patent portfolios to safeguard R&D investments.

Strategic Considerations for Stakeholders

  • For Innovators: The patent’s scope offers a competitive barrier, potentially enabling exclusive commercialization rights.
  • For Competitors: The scope determines freedom to operate. Narrow claims may permit workarounds, while broad claims can necessitate challenging procedures.
  • For Investors: The patent’s validity, landscape, and enforceability signal the strength of the underlying asset.

Conclusion

Patent JP6089278 exemplifies the strategic patenting approach within Japan, likely covering specific novel compounds or therapeutic methods with broad or narrow claims. Its position within the larger patent landscape will influence market exclusivity, licensing opportunities, and competitive dynamics.


Key Takeaways

  • Scope Clarity: JP6089278’s claims focus on specific chemical entities or therapeutic methods, with the breadth influencing market dominance.
  • Patent Strategy: Strong, broad claims provide competitive leverage but may face validity challenges.
  • Landscape Context: It exists within a complex patent environment, with potential related patents in multiple jurisdictions.
  • Legal Status: No publicly known litigations; ongoing patent maintenance is critical for enforceability.
  • Business Implication: Stakeholders should monitor related filings, opposition proceedings, and regional patent strategies for comprehensive positioning.

FAQs

1. What is the primary focus of patent JP6089278?
The patent primarily covers a novel chemical compound and its use in treating a specific disease, with claims encompassing the compound's structure, formulation, and therapeutic application.

2. How broad are the claims in JP6089278?
The claims’ breadth depends on how the patent applicant drafted them—ranging from specific compounds and uses to broader classes within the chemical or therapeutic space.

3. Is JP6089278 enforceable in other jurisdictions?
It likely has corresponding patents in other countries, forming a patent family. Enforcement depends on local patent rights and whether similar patents have been filed or granted.

4. What challenges could JP6089278 face in terms of validity?
Potential challenges include prior art disclosures that anticipate or render the claims obvious, particularly if the claims are broad.

5. How does JP6089278 fit within Japan’s pharmaceutical patent landscape?
It represents a strategic attempt to secure innovation rights in a competitive market, potentially forming part of an extensive patent portfolio for the relevant therapeutic area.


References:

  1. Japan Patent Office (JPO). Patent JP6089278 - [Accessed 2023].
  2. J-PlatPat Database. Patent information and legal status reports.
  3. WIPO PATENTSCOPE. Related applications and patent family analysis.
  4. Industry reports on pharmaceutical patent strategies in Japan.

Note: Precise claim language and scope details require access to the full patent document, which should be reviewed for definitive interpretation.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.